Edesa Biotech, Inc. (EDSA) vs Filana Therapeutics, Inc. (FLNA)

A side-by-side comparison of Edesa Biotech, Inc. and Filana Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Edesa Biotech, Inc. logo
EDSA
Edesa Biotech, Inc.
$37M
$3.88HealthcareDelayed quote: Oct 6, 2026, 1:15 PM EDT
Filana Therapeutics, Inc. logo
FLNA
Filana Therapeutics, Inc.
$40M
$0.83HealthcareDelayed quote: Oct 6, 2026, 1:20 PM EDT

Total return — EDSA vs FLNA

growth of $100 · dividends reinvested · last 1y
EDSA +265.4% (+265.4%/yr)FLNA -57.6% (-57.6%/yr)EDSA compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $100$365$42
EDSA FLNA

EDSA vs FLNA: by the numbers

  • •FLNA is the larger company ($40M vs $37M market cap).

Metrics side by side

Valuation

MetricEDSAFLNA
P/B ratio93.560.63

Profitability

MetricEDSAFLNA
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-160.05%-66.47%
ROIC-166.02%-72.12%

Growth (annualized)

MetricEDSAFLNA
Total return CAGR (5Y)-39.88%N/A

Go deeper

Full EDSA analysisFull FLNA analysisInteractive comparison tool

Dig into the metrics

Edesa Biotech ROEFilana Therapeutics ROEEdesa Biotech operating marginFilana Therapeutics operating marginEdesa Biotech revenue growthFilana Therapeutics revenue growthEdesa Biotech free cash flowFilana Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.